Carvedilol Tablet, Film Coated
Product Images NDC 50090-6865

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-6865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line graph depicting percent mortality over 21 months comparing Carvedilol and placebo groups. The x-axis represents time in months, and the y-axis shows percent mortality. The Carvedilol group exhibits consistently lower mortality rates than the placebo group throughout the study period.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A forest plot showing hazard ratios with confidence intervals for various patient subgroups including men, women, age groups, racial groups, diabetic status, ischemic versus nonischemic conditions, heart rate categories, systolic blood pressure levels, and spironolactone use. The x-axis represents the hazard ratio scale from 0.0 to 2.0 with a reference line at 1.0.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A survival analysis line graph titled 'Survival Analysis for CAPRICORN (intent-to-treat)' depicting percentage mortality over 24 months. The graph compares two groups labeled Placebo and Carvedilol, with mortality on the y-axis and time in months on the x-axis. The graph shows lower mortality for Carvedilol compared to Placebo, with a P value of 0.03 indicated.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A forest plot titled 'Figure 4. Effects on Mortality for Subgroups in CAPRICORN' showing hazard ratios for mortality across various patient subgroups, including age, gender, timing post-MI, prior treatments, Killip class, thrombolytic use, PTCA for MI, heart failure status, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Hazard ratios and confidence intervals are plotted horizontally with reference line at 1.0.*
FDA Label Image

Label Image (Lbl500906865)

Label Image (Lbl500906865)
Carvedilol 6.25 mg film-coated tablets label from A-S Medication Solutions. The label includes NDC 50090-6865, lot number S5975-0, and states that each tablet contains 6.25 mg carvedilol USP. The package contains 90 tablets with storage instructions and a QR code for dosage information.*
FDA Label Image
Logo (Logo)
FDA Label Image

Logo1 (Logo1)

Logo1 (Logo1)
FDA Label Image

Carvedilol-chemical-structure (Structure)

Carvedilol-chemical-structure (Structure)
Chemical structure of carvedilol, showing its molecular arrangement including aromatic rings, hydroxyl, amine, and methoxy groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.